FREYMAN THOMAS C 4

What Happened
Thomas C. Freyman, a director of AbbVie Inc. (ABBV), was granted 1,118 restricted stock units (RSUs) on 2026-05-08. The award is reported at $0.00 per unit (transaction code A) because these are compensation awards rather than an open-market purchase or sale. RSUs will be settled one-for-one into AbbVie common stock upon the earlier of the director’s separation from service, death, or a change in control under the company’s 2013 Incentive Stock Program.

Key Details

• Transaction date: 2026-05-08; Form 4 filed: 2026-05-12 (filed within the standard two-business-day window).
• Security: Restricted stock units (RSUs); Amount: 1,118 units; Reported price: $0.00 (award).
• Shares owned after transaction: Not specified on this Form 4.
• Footnotes: F1 explains RSUs vest/settle 1:1 upon separation, death, or change in control. F2 and F3 note certain shares are held in trusts (spouse is trustee) and the reporting person disclaims beneficial ownership of those trust-held shares.
• Transaction code: A = Award/Grant.

Context
RSU awards to directors are routine compensation and do not represent an open-market purchase or sale that would signal immediate bullish or bearish insider sentiment. The award becomes actual AbbVie shares only upon the specified triggering events (separation, death, or change in control). Trust-related disclosures simply describe legal ownership arrangements and do not necessarily indicate trading intent.